LAURA JETTER: Open Payments
NPI 1467964056 · CUMMING, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,174 in 55 payments from 15 companies in 2025. Trend: 2023 $693 · 2024 $940 · 2025 $1,174
Food & beverage: $937Education: $237
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 25 | $379 |
| AstraZeneca Pharmaceuticals LP | 11 | $254 |
| SANOFI-AVENTIS U.S. LLC | 3 | $237 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| Genentech USA, Inc. | 2 | $37 |
| AtriCure, Inc. | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Galderma Laboratories, L.P. | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $17 |
Products named: DUPIXENT, TEZSPIRE, AIRSUPRA, Rhapsido, FASENRA, Xolair, ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM, TAKHZYRO.
Industry payments across IA — which companies pay providers there.
